Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,156 | -18,025 | -19,657 | -12,826 | N/A |
| Depreciation Amortization | 410 | 438 | 448 | 364 | N/A |
| Accounts receivable | N/A | N/A | N/A | 839 | N/A |
| Accounts payable and accrued liabilities | 1,021 | -211 | 50 | 632 | N/A |
| Other Working Capital | 1,113 | 1,656 | -84 | 1,543 | N/A |
| Other Operating Activity | 2,305 | 2,648 | 151 | -1,421 | 0 |
| Operating Cash Flow | $-29,307 | $-13,494 | $-19,092 | $-10,869 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -137 | N/A | -110 | -805 | N/A |
| Investing Cash Flow | $-137 | $N/A | $-110 | $-805 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,883 | 6,500 | 1,947 | N/A | N/A |
| Debt Repayment | -4,633 | -511 | -955 | -583 | N/A |
| Common Stock Issued | 70,311 | 31 | 6 | 33 | N/A |
| Common Stock Repurchased | N/A | N/A | -5 | -2 | N/A |
| Other Financing Activity | 0 | 7,534 | 25,391 | 11,000 | 0 |
| Financing Cash Flow | $75,561 | $13,554 | $26,384 | $10,448 | $N/A |
| Beginning Cash Position | 7,942 | 7,882 | 700 | 1,926 | N/A |
| End Cash Position | 54,059 | 7,942 | 7,882 | 700 | N/A |
| Net Cash Flow | $46,117 | $60 | $7,182 | $-1,226 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,307 | -13,494 | -19,092 | -10,869 | N/A |
| Capital Expenditure | -137 | N/A | -110 | -805 | N/A |
| Free Cash Flow | -29,444 | -13,494 | -19,202 | -11,674 | 0 |